Close X
Wednesday, December 4, 2024
ADVT 
National

As CMA votes to oppose smoking plants, Tom Mulcair calls pot-puffing personal choice

Lee-Anne Goodman, The Canadian Press, 20 Aug, 2014 03:17 PM
  • As CMA votes to oppose smoking plants, Tom Mulcair calls pot-puffing personal choice
OTTAWA - Tom Mulcair defended the use of marijuana as a matter of personal choice Wednesday, recalling his own youth puffing on "oregano" even as the Canadian Medical Association officially warned against smoking pot.
 
In remarks on the sidelines of the CMA meeting, the NDP leader stopped short of echoing Justin Trudeau's call to legalize marijuana, saying there are still issues that need to be examined before that happens.
 
"The NDP for 40 years has believed that it makes no sense at all for a person to have a criminal record for possession or personal use of a small amount of marijuana," Mulcair said when asked why his party isn't backing Trudeau's stance.
 
"But what we are also saying is that there are a lot of complex issues, including supply, that have to be looked at in a lot more detailed fashion.... There is still a fair amount of hard work to be done to be able to get to solutions."
 
Mulcair didn't specifically raise any health concerns about weed, disputing a suggestion that it's a gateway drug. That's a "very 1960s argument" that has been widely debunked, Mulcair told a news conference.
 
But just upstairs a few hours later, CMA delegates voted to formally oppose the smoking of any plant substance, including cannabis.
 
Louis Hugo Francescutti, the outgoing head of the CMA, said smoking plants has a detrimental impact on the lungs' "natural cleaning and repair system" and can trap carcinogenics in the lungs.
 
He pointed to a 2008 study by the American Chemical Society that found marijuana fumes are rife with just as many chemicals as tobacco smoke, but at higher levels.
 
Chris Simpson, the CMA's new president, opined that weed could be more harmful than tobacco because pot-smokers inhale more deeply. But he reiterated the CMA's long-standing position, similar to Mulcair's, that marijuana should be decriminalized.
 
In Vancouver on Tuesday, Justice Minister Peter MacKay said the federal government is still assessing whether to allow police to ticket people caught with small amounts of marijuana instead of pursuing criminal charges.
 
Ahead of a meeting with law enforcement officials in Vancouver, MacKay said any change in legislation would have to happen within the next six months.
 
In his speech, Mulcair accused the Tories of unsuccessfully trying to recruit Canadian doctors in an ideological crusade against marijuana.
 
Three medical groups, including the CMA, recently turned down a request by Ottawa to participate in a campaign to raise awareness about the dangers of marijuana use to Canadian youth. They said the issue had become a "political football."
 
Trudeau called the proposed campaign a thinly veiled attack on his pro-legalization stance. Health Minister Rona Ambrose, who spoke at the conference earlier this week, scoffed at the Liberal leader's charge.
 
Mulcair stated the obvious on Tuesday — the tide is turning on public perceptions about marijuana.
 
"Everything is moving in the same direction; even the Canadian Association of the Chiefs of Police is saying we should move away from the current system," he said after his speech, the first at the CMA conference by an Opposition leader.
 
And he recalled his own experiences with weed.
 
"When I was a student it was part of the culture, but what we were smoking back then was about as strong as oregano compared to what's on the market today," he said.
 
The fact that it's stronger now, however, doesn't change his views, he added. "I think it's a matter of personal choice."

MORE National ARTICLES

Tekmira in talks about using experimental Ebola drug in infected patients

Tekmira in talks about using experimental Ebola drug in infected patients
VANCOUVER - Tekmira Pharmaceuticals Corp. (TSX:TKM) is in discussions about making its experimental Ebola drug available to infected patients, but says there is no guarantee the treatment can be used to help quell the outbreak in West Africa.

Tekmira in talks about using experimental Ebola drug in infected patients

Vancouver police officer used too much force during traffic stop: watchdog

Vancouver police officer used too much force during traffic stop: watchdog
A Vancouver police officer used excessive and unnecessary force when he punched a driver three times during a traffic stop in 2012, said a ruling by B.C.'s police watchdog.

Vancouver police officer used too much force during traffic stop: watchdog

Fleet of six new Bitcoin ATMs arrive in shopping centres across Toronto

Fleet of six new Bitcoin ATMs arrive in shopping centres across Toronto
A Calgary company is looking to boost the profile of the world's newest, and most controversial, currency with the launch of six more teller machines in Toronto that deal in the virtual currency Bitcoin.

Fleet of six new Bitcoin ATMs arrive in shopping centres across Toronto

White House talking to Canada, others about aiding Iraqi refugees

White House talking to Canada, others about aiding Iraqi refugees
The United States is considering a multinational mission to whisk displaced people to safety in Iraq and it appears there may be a supporting role for Canada.

White House talking to Canada, others about aiding Iraqi refugees

B.C. special prosecutor approves polygamy charges against 4 people in Bountiful

B.C. special prosecutor approves polygamy charges against 4 people in Bountiful
A special prosecutor has approved polygamy charges against the two leaders of an isolated religious sect in southeastern British Columbia.

B.C. special prosecutor approves polygamy charges against 4 people in Bountiful

Ebola drug developer Tekmira's net loss widens during second quarter

Ebola drug developer Tekmira's net loss widens during second quarter
Tekmira Pharmaceuticals Corp. (TSX:TKM) says it's in talks with governments and non-governmental organizations in various countries about the potential use of its experimental Ebola drug in infected patients.

Ebola drug developer Tekmira's net loss widens during second quarter